Edition:
United States

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
4:00pm EDT
Change (% chg)

$-0.06 (-2.87%)
Prev Close
$2.09
Open
$2.09
Day's High
$2.13
Day's Low
$2.03
Volume
4,083
Avg. Vol
16,365
52-wk High
$11.90
52-wk Low
$1.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 -0.006
Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 10.00 10.00 10.00 0.00
Quarter Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 5.00 10.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 1 -0.26 -0.26 -0.26 --
Quarter Ending Dec-18 1 -0.23 -0.23 -0.23 --
Year Ending Dec-18 1 -0.90 -0.90 -0.90 -2.41
Year Ending Dec-19 1 -0.83 -0.83 -0.83 -3.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 212.74 32.86
P/E High - Last 5 Yrs. -- 283.39 47.09
P/E Low - Last 5 Yrs. -- 96.61 24.92
Beta -7.50 0.76 0.81
Price to Sales (TTM) -- 257.41 8.16
Price to Book (MRQ) 1.60 20.98 4.20
Price to Tangible Book (MRQ) 1.62 27.14 6.23
Price to Cash Flow (TTM) -- 126.87 22.15
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.28 -6.24
Payout Ratio(TTM) -- 84.11 46.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.11 4.76
Sales (TTM) vs TTM 1 Yr. Ago -- 146.94 12.07
Sales - 5 Yr. Growth Rate -- 30.62 7.67
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.23 -78.76 48.53
EPS (TTM) vs TTM 1 Yr. Ago -69.76 -- --
EPS - 5 Yr. Growth Rate -- 46.50 7.99
Capital Spending - 5 Yr. Growth Rate -- 42.39 7.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.56
Current Ratio (MRQ) 3.19 6.61 3.63
LT Debt to Equity (MRQ) -- 24.43 13.24
Total Debt to Equity (MRQ) -- 28.63 17.38
Interest Coverage (TTM) -- -156.28 35.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.88 55.29
Gross Margin - 5 Yr. Avg. -- 53.35 53.23
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -181.46 15.62
Operating Margin (TTM) -- -962.40 -0.76
Operating Margin - 5 Yr. Avg. -- -195.12 10.76
Pre-Tax Margin (TTM) -- -855.13 1.14
Pre-Tax Margin - 5 Yr. Avg. -- -199.56 10.90
Net Profit Margin (TTM) -- -846.38 -2.16
Net Profit Margin - 5 Yr. Avg. -- -197.25 7.25
Effective Tax Rate (TTM) -- 14.83 20.78
Effective Tax Rate - 5 Yr. Avg. -- 19.08 24.32

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,266,505 732,349,814
Net Income/Employee (TTM) -- -907,431 85,388,927
Receivable Turnover (TTM) -- 17.77 5.94
Inventory Turnover (TTM) -- 2.86 3.70
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -86.95 -2.28 10.32
Return on Assets - 5 Yr. Avg. -71.51 2.92 10.99
Return on Investment (TTM) -120.23 -3.73 13.13
Return on Investment - 5 Yr. Avg. -101.20 2.73 14.20
Return on Equity (TTM) -120.46 -5.79 15.07
Return on Equity - 5 Yr. Avg. -102.45 -4.40 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -69.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.44%
# of Holders: 12
Total Shares Held: 1,592,103
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.